Back to search
Primary Generalized Tonic-Clonic Seizures
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Generalized Tonic-Clonic Seizures trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Generalized Tonic-Clonic Seizures trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 admini…
This is a randomized trial for patients with brain metastases in the primary motor cortex who have not had seizures to receive either the prophylactic anti-seiz…
The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[inclu…
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025 (core study)
To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduction of primary generalized seizures in…